Entellus Medical, Inc.
(NASDAQ : ENTL)

( )
ENTL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific Inc.
-0.34%230.011.0%$371.70m
ISRGIntuitive Surgical, Inc.
0.20%524.922.4%$370.22m
MDTMedtronic PLC
-0.59%90.560.6%$368.91m
ALGNAlign Technology, Inc.
1.74%357.306.3%$295.74m
ABTAbbott Laboratories
0.86%64.710.8%$290.10m
ABMDABIOMED, Inc.
-2.75%358.823.3%$250.70m
BSXBoston Scientific Corporation
0.38%34.421.1%$244.85m
BDXBecton, Dickinson and Company
0.16%253.041.1%$238.44m
BAXBaxter International Inc.
0.62%72.021.7%$228.12m
SYKStryker Corporation
0.77%169.991.3%$220.63m
EWEdwards Lifesciences Corporation
0.24%139.721.2%$187.71m
DXCMDexCom, Inc.
2.07%130.968.6%$162.53m
ZBHZimmer Biomet Holdings, Inc.
0.89%123.851.7%$147.94m
XRAYDENTSPLY International Inc.
1.55%38.673.0%$137.13m
IDXXIDEXX Laboratories, Inc.
0.10%243.503.7%$108.59m

Company Profile

Entellus Medical, Inc. is a medical technology company focused on the design, development and commercialization of products for the treatment of chronic sinusitis. Its XprESS family of products is used by ear, nose and throat, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses. Entellus Medical was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Plymouth, MN.